Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VANISH: Clonidine for Obesity-Related Hypertension
NCT01983462Phase 2Terminated
- Start
- Oct 2013
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clonidine in hypertension (HTN). Started Oct 2013; status: terminated.
02
Drugs
clonidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01983462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01983462.